Schwab Charles Investment Management Inc. increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 1.1% during the first quarter, Holdings Channel reports. The institutional investor owned 3,746,418 shares of the pharmacy operator’s stock after buying an additional 40,014 shares during the period. Schwab Charles Investment Management Inc.’s holdings in CVS Health Corporation were worth $294,094,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in CVS. Mercer Capital Advisers Inc. bought a new stake in CVS Health Corporation during the first quarter valued at $118,000. Orrstown Financial Services Inc. raised its stake in CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock valued at $165,000 after buying an additional 2,000 shares in the last quarter. SRS Capital Advisors Inc. raised its stake in CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares in the last quarter. Edmp Inc. bought a new stake in CVS Health Corporation during the first quarter valued at $202,000. Finally, Pinnacle Bank bought a new stake in CVS Health Corporation during the first quarter valued at $203,000. Institutional investors own 81.92% of the company’s stock.

CVS Health Corporation (NYSE CVS) traded up 0.40% during midday trading on Friday, reaching $79.46. 860,803 shares of the company’s stock traded hands. CVS Health Corporation has a one year low of $69.30 and a one year high of $98.44. The stock’s 50 day moving average price is $78.77 and its 200-day moving average price is $78.97. The stock has a market cap of $80.78 billion, a PE ratio of 15.83 and a beta of 0.91.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter in the previous year, the business earned $1.32 EPS. CVS Health Corporation’s revenue was up 4.5% compared to the same quarter last year. Equities analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s payout ratio is currently 39.92%.

WARNING: “CVS Health Corporation (CVS) Shares Bought by Schwab Charles Investment Management Inc.” was posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.watchlistnews.com/cvs-health-corporation-cvs-shares-bought-by-schwab-charles-investment-management-inc/1475284.html.

Several research firms have recently weighed in on CVS. Vetr lowered shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 price objective for the company. in a research note on Monday, June 12th. Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Needham & Company LLC began coverage on shares of CVS Health Corporation in a research note on Tuesday, June 27th. They issued a “hold” rating for the company. Jefferies Group LLC reiterated a “hold” rating and issued a $82.00 price objective on shares of CVS Health Corporation in a research note on Friday, July 14th. Finally, BidaskClub lowered shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Eight research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. CVS Health Corporation currently has a consensus rating of “Buy” and an average target price of $91.27.

In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of the company’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the sale, the executive vice president now directly owns 59,300 shares in the company, valued at approximately $4,564,914. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO David M. Denton sold 230,510 shares of the company’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the sale, the chief financial officer now owns 176,983 shares of the company’s stock, valued at $14,158,640. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 271,175 shares of company stock valued at $21,632,597. 0.61% of the stock is owned by company insiders.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.